| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Professional Services | -- | -- | -- | -- | -- | -- | -- | -- | 270.54 | 250.35 |
| Maintenance | -- | -- | -- | -- | -- | -- | -- | -- | 460.14 | 439.00 |
| Information services | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| System sales | -- | -- | -- | -- | -- | -- | -- | -- | 145.27 | 227.91 |
| Software delivery, support and maintenance | 914.66 | 1,004.20 | 1,011.62 | 958.19 | 899.30 | 918.43 | 907.34 | 918.69 | -- | -- |
| Prepackaged medications | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Transaction processing and other | -- | -- | -- | -- | -- | -- | -- | -- | 570.37 | 526.82 |
| Client services | 588.04 | 628.42 | 606.22 | 539.52 | 486.77 | 467.96 | 470.53 | 454.38 | -- | -- |
| Total Revenues | 1,502.70 | 1,632.61 | 1,617.84 | 1,497.71 | 1,386.07 | 1,386.39 | 1,377.87 | 1,373.06 | 1,446.33 | 1,444.08 |
| Restructuring and other charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Prepackaged medications | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Information services | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of revenue: Maintenance | -- | -- | -- | -- | -- | -- | -- | -- | 145.35 | 135.57 |
| Cost of revenue: Professional services | -- | -- | -- | -- | -- | -- | -- | -- | 234.87 | 210.61 |
| Cost of revenue: System sales | -- | -- | -- | -- | -- | -- | -- | -- | 62.88 | 90.31 |
| Cost of revenue: Transaction processing and other | -- | -- | -- | -- | -- | -- | -- | -- | 331.27 | 288.19 |
| Cost of revenue: Software delivery, support and maintenance | 287.95 | 319.14 | 315.10 | 295.59 | 276.40 | 291.80 | 312.90 | 325.47 | -- | -- |
| Cost of revenue: Client services | 530.65 | 595.31 | 584.67 | 484.59 | 437.15 | 432.04 | 437.78 | 427.93 | -- | -- |
| Cost of revenue: Amortization of software development and acquisition-related assets (a) | 118.40 | 107.87 | 96.68 | 84.73 | 71.22 | 81.99 | 81.22 | 85.20 | 65.42 | 53.83 |
| Gross Profit | 565.70 | 610.29 | 621.39 | 632.80 | 601.30 | 580.57 | 545.98 | 534.46 | 606.54 | 665.57 |
| Goodwill impairment charge | 0.00 | 25.70 | 13.47 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Amortization of intangible assets | 25.60 | 27.19 | 26.56 | 17.35 | 15.88 | 23.17 | 31.28 | 31.25 | 35.64 | 37.34 |
| Research and development | 206.06 | 245.44 | 258.74 | 202.28 | 178.53 | 184.79 | 192.82 | 199.75 | 162.16 | 104.11 |
| Stock-based compensation expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative expenses | 389.94 | 400.81 | 432.85 | 400.69 | 334.52 | 339.18 | 358.68 | 419.60 | 384.37 | 387.57 |
| Restructuring and other charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Write-off of acquired in-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Asset impairment charge | (74.97) | (10.84) | (58.17) | 0.00 | (4.65) | (1.54) | (2.39) | (11.45) | (11.10) | 0.00 |
| Operating Income (loss) | (130.88) | (99.69) | (168.38) | 12.48 | 67.71 | 31.88 | (39.19) | (127.60) | 13.27 | 136.54 |
| Interest expense | 34.10 | 43.17 | 50.91 | 37.54 | 29.48 | 31.40 | 29.30 | 28.06 | 16.19 | 20.75 |
| Gain on sale of equity investment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Equity in net earnings of unconsolidated investments | 17.19 | 0.67 | 0.26 | 0.82 | (7.50) | (2.10) | (0.40) | 0.00 | -- | -- |
| Impairment of long-term investments | (1.58) | (0.65) | (15.49) | (165.29) | 0.00 | 0.00 | -- | -- | -- | -- |
| Interest income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other income (expense) net | 0.05 | (138.90) | 0.07 | (0.51) | 0.83 | 2.18 | 0.77 | 7.31 | (14.54) | 1.69 |
| Gain on sale of business, net | 0.00 | 0.00 | 172.26 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Income from operations before income taxes | (149.31) | (281.75) | (62.20) | (190.04) | 31.56 | 0.57 | (68.12) | (148.35) | (17.46) | 117.48 |
| Current: Federal | -- | -- | -- | -- | 0.37 | 0.57 | 0.84 | (0.45) | 1.61 | 2.83 |
| Current: State | -- | -- | -- | -- | 0.63 | 0.66 | 0.21 | 1.42 | 3.79 | 4.69 |
| Deferred: Federal | -- | -- | -- | -- | (3.78) | (2.93) | (0.58) | (43.54) | (24.20) | 36.64 |
| Deferred: State | -- | -- | -- | -- | 0.12 | 0.90 | (3.26) | (7.93) | (2.47) | (2.39) |
| Provision (benefit) for income taxes | (16.69) | (43.34) | (18.98) | (5.51) | 0.31 | 2.63 | (1.66) | (44.32) | (16.31) | 43.87 |
| Current tax provision - Foreign | -- | -- | -- | -- | 3.86 | 4.08 | (0.40) | 0.05 | 5.18 | 2.48 |
| Deferred tax provision - Foreign | -- | -- | -- | -- | (0.88) | (0.66) | 1.52 | 6.13 | (0.23) | (0.37) |
| Loss from continuing operations | (132.62) | (238.41) | (43.22) | (184.52) | 31.25 | (2.06) | -- | -- | -- | -- |
| Income from discontinued operations | 71.45 | 75.24 | 2.50 | (11.92) | (46.34) | 0.00 | -- | -- | -- | -- |
| Gain from sale of discontinued operations | 1,156.50 | 0.00 | 500.47 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Income tax effect on discontinued operations | (394.93) | (19.43) | (51.95) | 42.26 | 18.12 | -- | -- | -- | -- | -- |
| Consolidated Net Income (Loss) | 700.41 | (182.60) | 407.81 | (154.18) | 3.03 | (2.06) | (66.45) | (104.03) | -- | -- |
| Less: Net income attributable to non-controlling interest | 0.00 | (0.42) | (4.53) | (1.57) | 0.15 | 0.17 | 0.00 | 0.00 | -- | -- |
| Accretion of mandatory redemption value of preferred shares and accrued dividends on preferred shares | 0.00 | 0.00 | 48.59 | 43.85 | 28.54 | 0.00 | 0.00 | -- | -- | -- |
| Net income (loss) attributable to common stockholders | 700.41 | (182.18) | 363.74 | (196.46) | (25.65) | (2.23) | (66.45) | (104.03) | (1.15) | 73.61 |
| Loss from continuing operations | (0.83) | (1.43) | (0.22) | (1.02) | 0.17 | (0.01) | -- | -- | -- | -- |
| EPS (Basic) : Discontinued operations | 5.23 | 0.33 | 2.29 | (0.07) | (0.31) | 0.00 | -- | -- | -- | -- |
| Gain from sale of discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings per share- Basic | 4.40 | (1.10) | 2.07 | (1.09) | (0.14) | (0.01) | (0.37) | (0.59) | (0.01) | 0.39 |
| Loss from continuing operations | (0.83) | (1.43) | (0.22) | (1.02) | 0.17 | (0.01) | -- | -- | -- | -- |
| EPS (Diluted) : Discontinued operations | 5.23 | 0.33 | 2.29 | (0.07) | (0.31) | 0.00 | -- | -- | -- | -- |
| Gain from sale of discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings per share- Diluted | 4.40 | (1.10) | 2.07 | (1.09) | (0.14) | (0.01) | (0.37) | (0.59) | (0.01) | 0.39 |
| Weighted average common shares outstanding : Basic | 159.28 | 166.31 | 176.04 | 180.83 | 186.19 | 185.08 | 179.85 | 177.03 | 178.70 | 189.25 |
| Weighted average common shares outstanding : Diluted | 159.28 | 166.31 | 176.04 | 180.83 | 186.19 | 185.08 | 179.85 | 177.03 | 178.70 | 191.04 |